Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproterone vs MPA vs Venlafaxine for Hot Flushes in Prostate Cancer
NCT01011751Phase 3Completed
- Sponsor
- Takeda
- Start
- Apr 2004
- Primary completion
- Dec 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hot flash comparing Cyproterone acetate, Medroxyprogesterone acetate and Venlafaxine (3 arms). Primary endpoint: Percent Change from Randomization in Hot Flushes Score at 4 weeks. Started Apr 2004; status: completed.
02
Drugs
cyproteronemedroxyprogesterone acetatevenlafaxine
03
Conditions
hot flash
Beyond the preview
Go deeper on NCT01011751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01011751.